Processa Pharmaceuticals (PCSA) Q2 2023 Earnings

10AugConfirmed
Aug 22
Nov 22
Q1 2023
Q2 2023
-0.81
-0.57
-0.34
-0.1

Details

Expected EPS
N/A
Actual EPS
-0.1
Surprise EPS
-0.1
Surprise Percent
+∞%

Description

Processa Pharmaceuticals (PCSA) has reported earnings of -0.1 per share for Q2 2023.

0 Comments

Share your thoughts